IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Portfolio Profile

CIK: 0001381843 | STOCKHOLM, V7

Investment Profile

Style

Growth

Turnover

High

Orientation

Concentrated trader
$371.7M
AUM
39
Positions
48%
Top 10 Conc.
83.67%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1ELI Lilly & Co(LLY)29,821$35.8M9.62%
2Merck & Co. Inc(MRK)189,357$24.3M6.55%
3Johnson & Johnson(JNJ)85,425$21.7M5.84%
4Abbvie Inc(ABBV)64,325$16.2M4.35%
5CVS Health Corp(CVS)146,102$15.1M4.07%
6

Sector Allocation

Latest filing, equity positions only

Healthcare97.73% · $363.3M
Unclassified2.27% · $8.4M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.22%97.73%-0.49%
Unclassified1.78%2.27%+0.49%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$51.8M | 53 pos.
$127.8M | 45 pos.
$164.4M | 44 pos.
$164.0M | 38 pos.
$212.8M | 36 pos.
$210.8M | 36 pos.
Thermo Fisher Scientific Corp(TMO)
27,859
$14.0M
3.76%
7Revolution Medicines Inc(RVMD)73,077$13.7M3.68%
8Biogen Inc(BIIB)62,781$13.6M3.65%
9Neurocrine Biosciences Inc(NBIX)72,898$12.3M3.31%
10Mirum Pharmaceuticals Inc(MIRM)100,807$11.8M3.17%
Cap SizePrev %Curr %Change
Large Cap53.34%48.7%-4.64%
Mega Cap24.17%26.36%+2.19%
Mid Cap17.74%18.18%+0.44%
Small Cap2.45%3.72%+1.27%
Unclassified1.78%2.27%+0.49%
Micro Cap0.52%0.78%+0.26%
$226.5M | 37 pos.
$233.7M | 37 pos.
$27.0M | 38 pos.
$313.4M | 39 pos.
$309.7M | 39 pos.
$371.7M | 39 pos.
Q4
22
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

3
New
3
Closed
16
Increased
20
Decreased
0
Unchanged